II.1)
Scope of the procurement
IRLA - Antibodies and Sera (and other matrices)
Reference number:
LAB4042 SU
33651500
-
Immune sera and immunoglobulins
Supplies
II.1.4)
Short description
The supply of antibodies and sera (and other human and animal matrices).
Only members of www.apuc-scot.ac.uk , www.hepcw.ac.uk , www.lupc.ac.uk , www.neupc.ac.uk,www.nwupc.ac.uk , www.supc.ac.uk will have access to the agreement.
II.1.5)
Estimated total value
Value excluding VAT: 32100000.00
GBP
II.1.6)
Information about lots
This contract is divided into lots:
yes
Tenders may be submitted for
all lots
Maximum number of lots that may be awarded to one tenderer:
2
The contracting authority reserves the right to award contracts combining the following lots or groups of lots:
Lot 1 - Antibodies
Lot 2 - Sera and other matrices
II.2.2)
Additional CPV code(s)
33650000
-
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33651000
-
General anti-infectives for systemic use and vaccines
33651510
-
Antisera
33651520
-
Immunoglobulins
II.2.3)
Place of performance
Main site or place of performance:
Various locations across the UK.
II.2.4)
Description of the procurement
Precise product specifications and quantities are unknown to SUPC. These will be agreed with customers when they call-off the agreement.
Historical information has shown on average a £10M per year spend with Antibodies suppliers.
However, this is only an estimation and the value of purchases made under each Framework will depend on Institutions taking up the Frameworks and on suppliers promoting and adhering to the terms of their contracts
Price is not the only award criterion and all criteria are stated only in the procurement documents
Value excluding VAT: 25000000.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
30
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
yes
Description of options:
SUPC will award this Framework Agreement on the basis of 30 months, with 1 option to extend by up to an additional 6 months.
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
yes
Identification of the project:
Various projects funded by EU in research institutions in the UK
II.2.14)
Additional information
It is anticipated that some of the future call-off contracts under this framework will be part or fully funded from external streams, including European Union (EU) funding (ERDF/ESF) and potentially other research bodies. All funding accessed under this framework will be considered compliant for the purposes of external funding by the named participants.
Sera and other matrices
Lot No:
2
II.2.2)
Additional CPV code(s)
33651500
-
Immune sera and immunoglobulins
II.2.3)
Place of performance
Main site or place of performance:
Various locations across the UK
II.2.4)
Description of the procurement
Precise product specifications and quantities are unknown to SUPC. These will be agreed with customers calling-off the agreement.
Expenditure across sera suppliers was estimated at less than 2 500 000 GBP for sera, tissue and other blood products. However, this is only an estimation and the value of purchases made under each Framework will depend on Institutions taking up the Frameworks and on suppliers promoting and adhering to the terms of their contracts.
Price is not the only award criterion and all criteria are stated only in the procurement documents
Value excluding VAT: 7100000.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
30
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
yes
Description of options:
SUPC will award this Framework Agreement on the basis of 30 months, with 1 option to extend by up to an additional 6 months.
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
yes
Identification of the project:
Various projects funded by EU in research institutions in the UK
II.2.14)
Additional information
It is anticipated that some of the future call-off contracts under this framework will be part or fully funded from external streams, including European Union (EU) funding (ERDF/ESF) and potentially other research bodies. All funding accessed under this framework will be considered compliant for the purposes of external funding by the named participants.